OMICS Group organizing splendorous Pharmaceutical conferences focuses on the advancements in pharmacovigilance, preclinical, clinical trials and risk management. The field of Pharmacovigilance & Clinical trials is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Pharmacovigilance-2015  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of is Pharmacovigilance-2015 is “Reviving Strategies for Safer Therapeutics in Healthcare System".

UK proves to be perfect location for production, research and sales of world-class pharmaceuticals. UK ranks sixth in the pharmaceutical marketing and is home for GlaxoSmithKline and AstraZeneca. A new method (developed by the industry-based Office of Health Economics (OHE)) of projecting drug spending in the UK forecasts that the total market will show annual growth rates of 3.1%-4.1% to 2015, while sales in the branded segment will increase 0.5%-1.8% a year and total generics sales will grow 10%-11% yearly over the period.